TY - JOUR
T1 - Metabolic and behavioural risk factors for cardiovascular diseases in Southern Latin America
T2 - analysis of the Global Burden of Disease 1990–2019
AU - Briones-Valdivieso, C.
AU - Salerno, P. R.V.O.
AU - Navarrete-Muñoz, E. M.
AU - Valera-Gran, D.
AU - López-Bueno, R.
AU - Al-Kindi, S.
AU - Deo, S. V.
AU - Petermann-Rocha, F.
N1 - Publisher Copyright:
© 2024 The Royal Society for Public Health
PY - 2024/10
Y1 - 2024/10
N2 - Objectives: Cardiovascular diseases (CVDs) are the leading causes of global mortality. Modifiable behavioural and metabolic risk factors significantly contribute to the burden of CVD. Given the vast socio-demographic and health outcome heterogeneity in Latin America, similar southern Latin American countries (Argentina, Chile, and Uruguay) were analysed as a distinct group to describe the CVD death rates related to metabolic and behavioural risk factors. Study design: An ecological study was performed using data from the Global Burden of Disease Study 2019. Methods: Metabolic and behavioural risk factors-related CVD death were examined by analysing age-standardised rates per 100,000 individuals in the three countries between 1990 and 2019. Results: While exposure to behavioural risk is decreasing, an upwards trend was observed in metabolic risks. Among the assessed risk factors, metabolic factors emerged as the primary contributors to deaths. High fasting plasma glucose exhibited a remarkable increase in relative importance across most studied contexts. Dietary risks stood out among behavioural factors due to their complexity and substantial changes observed. Although mortality rates have declined for overall CVD, peripheral artery disease mortality is rising. Conclusion: Modifiable behavioural and metabolic risk factors significantly influence CVD mortality in Southern Latin America. Despite the increasing exposure to metabolic risks, advancements in prevention and treatment are evidenced in the decline of mortality rates for most CVD. These findings emphasise the need for targeted interventions and comprehensive strategies to address their impact on cardiovascular health, advocating for healthy lifestyle behaviours to mitigate the progression and CVD development.
AB - Objectives: Cardiovascular diseases (CVDs) are the leading causes of global mortality. Modifiable behavioural and metabolic risk factors significantly contribute to the burden of CVD. Given the vast socio-demographic and health outcome heterogeneity in Latin America, similar southern Latin American countries (Argentina, Chile, and Uruguay) were analysed as a distinct group to describe the CVD death rates related to metabolic and behavioural risk factors. Study design: An ecological study was performed using data from the Global Burden of Disease Study 2019. Methods: Metabolic and behavioural risk factors-related CVD death were examined by analysing age-standardised rates per 100,000 individuals in the three countries between 1990 and 2019. Results: While exposure to behavioural risk is decreasing, an upwards trend was observed in metabolic risks. Among the assessed risk factors, metabolic factors emerged as the primary contributors to deaths. High fasting plasma glucose exhibited a remarkable increase in relative importance across most studied contexts. Dietary risks stood out among behavioural factors due to their complexity and substantial changes observed. Although mortality rates have declined for overall CVD, peripheral artery disease mortality is rising. Conclusion: Modifiable behavioural and metabolic risk factors significantly influence CVD mortality in Southern Latin America. Despite the increasing exposure to metabolic risks, advancements in prevention and treatment are evidenced in the decline of mortality rates for most CVD. These findings emphasise the need for targeted interventions and comprehensive strategies to address their impact on cardiovascular health, advocating for healthy lifestyle behaviours to mitigate the progression and CVD development.
KW - Behavioural risk
KW - Cardiovascular disease
KW - Ischaemic heart disease
KW - Metabolic risk
KW - Peripheral artery disease
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=85201440525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85201440525&partnerID=8YFLogxK
U2 - 10.1016/j.puhe.2024.06.039
DO - 10.1016/j.puhe.2024.06.039
M3 - Article
C2 - 39163728
AN - SCOPUS:85201440525
SN - 0033-3506
VL - 235
SP - 211
EP - 218
JO - Public Health
JF - Public Health
ER -